Recalls / Firms / Merck & Co. Inc
Merck & Co. Inc
5 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-07-21 | Class II | Belsomra | Ongoing |
| 2014-01-13 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister (NDC 6658 | Terminated |
| 2014-01-13 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg, a) 30 count blister (NDC 6658 | Terminated |
| 2014-01-13 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister (NDC 6658 | Terminated |
| 2014-01-13 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg, a) 30 count blister (NDC 6658 | Terminated |